Corcept Therapeutics (CORT) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $110.16, -2.83% vs the prior close of $113.37.
- Volume 849.64K shares, 0.7x its 50-day average.
- New SEC filings: 4 (Oct 16, 2026).
- No new insider buys or sales reported since the prior session.
CORT dips 2.8% to $110.16, a 1-month low, 5 down days in a row. Closed at $110.16, -2.83% vs the prior close of $113.37. Day range $107.79–$113.64, opened at $113.64.
CORT daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — CORT dips 2.8% to $110.16, a 1-month low, 5 down days in a row
- Closed at $110.16, -2.83% vs the prior close of $113.37. Day range $107.79–$113.64, opened at $113.64.
- Volume was 849.64K shares, 0.7x its 50-day average of 1.17M.
- Price is -4.7% vs its 50-day average ($115.64) and +53.5% vs its 200-day average ($71.76).
- 52-week range $28.66–$126.38; today's close sits at 83% of that range, 12.8% below the 52-week high.
- That makes 5 straight losses.
Oct 15, 2026 — CORT dips 2.5% to $113.37, 4 down days in a row
- Closed at $113.37, -2.46% vs the prior close of $116.23. Day range $113.02–$117.48, opened at $116.31.
- Volume was 668.40K shares, 0.6x its 50-day average of 1.17M — lighter than usual.
- Price is -1.9% vs its 50-day average ($115.59) and +58.4% vs its 200-day average ($71.56).
- 52-week range $28.66–$126.38; today's close sits at 87% of that range, 10.3% below the 52-week high.
- That makes 4 straight losses.
Oct 14, 2026 — CORT dips 1.3% to $116.23, 3 down days in a row
- Closed at $116.23, -1.33% vs the prior close of $117.80. Day range $115.95–$122.21, opened at $117.94.
- Volume was 691.80K shares, 0.6x its 50-day average of 1.18M — lighter than usual.
- Price is +0.6% vs its 50-day average ($115.54) and +62.8% vs its 200-day average ($71.39).
- 52-week range $28.66–$126.38; today's close sits at 90% of that range, 8.0% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — CORT dips 2.8% to $117.80
- Closed at $117.80, -2.80% vs the prior close of $121.19. Day range $117.42–$122.81, opened at $121.83.
- Volume was 556.20K shares, 0.5x its 50-day average of 1.20M — lighter than usual.
- Price is +2.1% vs its 50-day average ($115.41) and +65.4% vs its 200-day average ($71.23).
- 52-week range $28.66–$126.38; today's close sits at 91% of that range, 6.8% below the 52-week high.
Oct 12, 2026 — CORT ends flat (+0.0%) to $121.19
- Closed at $121.19, +0.00% vs the prior close of $121.19. Day range $119.28–$122.09, opened at $121.24.
- Volume was 497.70K shares, 0.4x its 50-day average of 1.23M — lighter than usual.
- Price is +5.1% vs its 50-day average ($115.31) and +70.6% vs its 200-day average ($71.06).
- 52-week range $28.66–$126.38; today's close sits at 95% of that range, 4.1% below the 52-week high.
Oct 9, 2026 — CORT rises 2.2% to $121.19
- Closed at $121.19, +2.24% vs the prior close of $118.54. Day range $117.41–$122.34, opened at $118.00.
- Volume was 624.20K shares, 0.5x its 50-day average of 1.31M — lighter than usual.
- Price is +5.2% vs its 50-day average ($115.18) and +71.0% vs its 200-day average ($70.86).
- 52-week range $28.66–$126.38; today's close sits at 95% of that range, 4.1% below the 52-week high.
Oct 8, 2026 — CORT dips 0.9% to $118.54
- Closed at $118.54, -0.89% vs the prior close of $119.60. Day range $115.80–$119.16, opened at $118.56.
- Volume was 496.60K shares, 0.4x its 50-day average of 1.33M — lighter than usual.
- Price is +3.0% vs its 50-day average ($115.12) and +67.7% vs its 200-day average ($70.68).
- 52-week range $28.66–$126.38; today's close sits at 92% of that range, 6.2% below the 52-week high.
Oct 7, 2026 — CORT ends flat (+0.0%) to $119.60
- Closed at $119.60, +0.03% vs the prior close of $119.57. Day range $117.23–$122.00, opened at $119.00.
- Volume was 634.90K shares, 0.5x its 50-day average of 1.33M — lighter than usual.
- Price is +4.4% vs its 50-day average ($114.61) and +69.6% vs its 200-day average ($70.51).
- 52-week range $28.66–$126.38; today's close sits at 93% of that range, 5.4% below the 52-week high.
Oct 6, 2026 — CORT dips 2.0% to $119.57
- Closed at $119.57, -2.02% vs the prior close of $122.03. Day range $115.11–$122.54, opened at $122.20.
- Volume was 790.00K shares, 0.6x its 50-day average of 1.35M — lighter than usual.
- Price is +4.8% vs its 50-day average ($114.10) and +70.0% vs its 200-day average ($70.31).
- 52-week range $28.66–$126.38; today's close sits at 93% of that range, 5.4% below the 52-week high.
Oct 5, 2026 — CORT jumps 5.0% to $122.03, a 1-month high
- Closed at $122.03, +4.99% vs the prior close of $116.23. Day range $115.50–$122.81, opened at $115.59.
- Volume was 1.00M shares, 0.7x its 50-day average of 1.35M.
- Price is +7.5% vs its 50-day average ($113.53) and +74.0% vs its 200-day average ($70.13).
- 52-week range $28.66–$126.38; today's close sits at 96% of that range, 3.4% below the 52-week high.
Oct 2, 2026 — CORT rises 1.9% to $116.23
- Closed at $116.23, +1.93% vs the prior close of $114.03. Day range $113.90–$117.32, opened at $114.38.
- Volume was 960.20K shares, 0.7x its 50-day average of 1.35M.
- Price is +2.9% vs its 50-day average ($113.00) and +66.2% vs its 200-day average ($69.92).
- 52-week range $28.66–$126.38; today's close sits at 90% of that range, 8.0% below the 52-week high.
CORT latest news & SEC filings
Every SEC filing by or about CORT in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Wilson James N sold 6,654 shares at $114.48 (≈$761.72K) on Oct 15, 2026; now holds 1,057,889
- Wilson James N sold 3,046 shares at $115.39 (≈$351.48K) on Oct 15, 2026; now holds 1,054,843
- Wilson James N sold 300 shares at $116.30 (≈$34.89K) on Oct 15, 2026; now holds 1,054,543
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Vieira Roberto Wandenkolk converted options/RSUs into 8,333 shares at $21.63 (≈$180.24K) on Oct 2, 2026; now holds 12,279
- Vieira Roberto Wandenkolk sold 1,100 shares at $114.52 (≈$125.97K) on Oct 2, 2026; now holds 11,179
- Vieira Roberto Wandenkolk sold 2,086 shares at $115.73 (≈$241.41K) on Oct 2, 2026; now holds 9,093
- Vieira Roberto Wandenkolk sold 5,147 shares at $116.58 (≈$600.06K) on Oct 2, 2026; now holds 3,946
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Lyon Joseph Douglas converted options/RSUs into 810 shares at $13.56 (≈$10.98K) on Oct 1, 2026; now holds 6,493
- Lyon Joseph Douglas sold 810 shares at $115.40 (≈$93.47K) on Oct 1, 2026; now holds 5,683
- Lyon Joseph Douglas converted options/RSUs into 3,357 shares at $13.56 (≈$45.52K) on Oct 2, 2026; now holds 9,040
- Lyon Joseph Douglas converted options/RSUs into 5,833 shares at $19.26 (≈$112.34K) on Oct 2, 2026; now holds 14,873
- Lyon Joseph Douglas sold 4,446 shares at $115.70 (≈$514.39K) on Oct 2, 2026; now holds 10,427
- Lyon Joseph Douglas sold 4,744 shares at $116.54 (≈$552.87K) on Oct 2, 2026; now holds 5,683
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Maduck Sean converted options/RSUs into 413 shares at $8.27 (≈$3.42K) on Oct 1, 2026; now holds 10,351
- Maduck Sean sold 413 shares at $115.54 (≈$47.72K) on Oct 1, 2026; now holds 9,938
- Maduck Sean converted options/RSUs into 24,587 shares at $8.27 (≈$203.33K) on Oct 2, 2026; now holds 34,525
- Maduck Sean sold 15,843 shares at $116.12 (≈$1.84M) on Oct 2, 2026; now holds 18,682
- Maduck Sean sold 8,744 shares at $116.55 (≈$1.02M) on Oct 2, 2026; now holds 9,938
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 5, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Sep 23, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 13, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 29, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $256.15M (prior year $194.43M) (+31.7% vs Jun 30, 2025)
- Net income: $42.99M (prior year $35.15M) (+22.3% vs Jun 30, 2025)
- Diluted EPS: $0.36 (prior year $0.29) (+24.1% vs Jun 30, 2025)
Jul 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade CORT
- Last results release: Jul 29, 2026 (8-K Item 2.02). Previous ones: Apr 30, 2026, Feb 24, 2026, Nov 4, 2025. Based on that rhythm, the next report is likely around Oct 28, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.07% (largest 5.0%).
- Liquidity: about 821.43K shares (≈$90.49M) trade per day on average.
- 52-week position: $110.16 vs a range of $28.66–$126.38 (83% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Roberto Wandenkolk Vieira sold 296 shares on Sep 16, 2026.
- Latest filings: 8-K Sep 23, 2026; 10-Q Jul 29, 2026; 8-K Jul 29, 2026.
- Share count: 108.10M shares outstanding (Jul 22, 2026), +2.6% vs a year earlier.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
CORT market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 113.64 | 113.64 | 107.79 | 110.16 | 849.64K |
| Oct 15, 2026 | 116.31 | 117.48 | 113.02 | 113.37 | 668.40K |
| Oct 14, 2026 | 117.94 | 122.21 | 115.95 | 116.23 | 691.80K |
| Oct 13, 2026 | 121.83 | 122.81 | 117.42 | 117.80 | 556.20K |
| Oct 12, 2026 | 121.24 | 122.09 | 119.28 | 121.19 | 497.70K |
| Oct 9, 2026 | 118.00 | 122.34 | 117.41 | 121.19 | 624.20K |
| Oct 8, 2026 | 118.56 | 119.16 | 115.80 | 118.54 | 496.60K |
| Oct 7, 2026 | 119.00 | 122.00 | 117.23 | 119.60 | 634.90K |
| Oct 6, 2026 | 122.20 | 122.54 | 115.11 | 119.57 | 790.00K |
| Oct 5, 2026 | 115.59 | 122.81 | 115.50 | 122.03 | 1.00M |
| Oct 2, 2026 | 114.38 | 117.32 | 113.90 | 116.23 | 960.20K |
| Oct 1, 2026 | 114.29 | 115.98 | 111.94 | 114.03 | 879.00K |
| Sep 30, 2026 | 114.80 | 118.07 | 113.98 | 115.23 | 910.30K |
| Sep 29, 2026 | 115.92 | 120.51 | 113.16 | 114.74 | 964.40K |
| Sep 28, 2026 | 116.00 | 117.07 | 114.36 | 115.63 | 1.15M |
| Sep 25, 2026 | 119.00 | 120.44 | 114.51 | 116.10 | 800.80K |
| Sep 24, 2026 | 111.86 | 119.15 | 111.68 | 118.51 | 983.60K |
| Sep 23, 2026 | 117.33 | 118.79 | 112.05 | 112.94 | 809.80K |
| Sep 22, 2026 | 113.96 | 119.00 | 113.09 | 117.51 | 810.20K |
| Sep 21, 2026 | 110.29 | 116.65 | 109.00 | 113.76 | 1.35M |
About Corcept Therapeutics
Corcept Therapeutics (CORT) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in REDWOOD CITY, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1088856.
CORT board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Gregg H Alton | Director | May 26, 2026 |
| G Leonard Jr Baker | Director | May 26, 2026 |
| Joseph K Belanoff | Chief Executive Officer | Jun 2, 2026 |
| David L Mahoney | Director | Aug 20, 2026 |
| Joshua M. Murray | Director | May 26, 2026 |
| Kimberly Park | Director | Aug 28, 2026 |
| Daniel N Jr Swisher | Director | May 26, 2026 |
| James N Wilson | Director | Sep 16, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Joseph K Belanoff | Chief Executive Officer | Jun 2, 2026 |
| William Guyer | Chief Development Officer | Sep 3, 2026 |
| Hazel Hunt | Chief Scientific Officer | Mar 3, 2026 |
| Joseph Douglas Lyon | See Remarks | Sep 16, 2026 |
| Sean Maduck | See Remarks | Sep 3, 2026 |
| Atabak Mokari | Chief Financial Officer | Sep 3, 2026 |
| Gary Charles Robb | Chief Business Officer | Sep 28, 2026 |
| Roberto Wandenkolk Vieira | President, Oncology | Sep 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 16, 2026 | Roberto Wandenkolk Vieira | Sale | 296 | $100.82 |
| Sep 16, 2026 | Roberto Wandenkolk Vieira | Sale | 296 | $100.82 |
| Sep 16, 2026 | Roberto Wandenkolk Vieira | Sale | 296 | $100.82 |
| Sep 16, 2026 | Roberto Wandenkolk Vieira | Sale | 296 | $100.82 |
| Sep 15, 2026 | James N Wilson | Sale | 2,800 | $111.70 |
| Sep 15, 2026 | James N Wilson | Sale | 400 | $110.84 |
| Sep 15, 2026 | James N Wilson | Sale | 6,800 | $110.27 |
| Sep 15, 2026 | James N Wilson | Sale | 2,800 | $111.70 |
| Sep 15, 2026 | James N Wilson | Sale | 400 | $110.84 |
| Sep 15, 2026 | James N Wilson | Sale | 6,800 | $110.27 |
| Sep 15, 2026 | James N Wilson | Sale | 2,800 | $111.70 |
| Sep 15, 2026 | James N Wilson | Sale | 400 | $110.84 |
| Sep 15, 2026 | James N Wilson | Sale | 6,800 | $110.27 |
| Sep 15, 2026 | James N Wilson | Sale | 2,800 | $111.70 |
| Sep 15, 2026 | James N Wilson | Sale | 400 | $110.84 |
CORT financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $761.41M | $99.65M | 0.82 | $142.00M |
| Dec 31, 2024 | $675.04M | $141.21M | 1.23 | $198.29M |
| Dec 31, 2023 | $482.38M | $106.14M | 0.94 | $126.68M |
| Dec 31, 2022 | $401.86M | $101.42M | 0.87 | $120.32M |
| Dec 31, 2021 | $365.98M | $112.51M | 0.89 | $167.89M |
Latest balance sheet: total assets $888.70M, total liabilities $182.93M, cash $111.04M (as of Jun 30, 2026).
CORT earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 29, 2026 | 8-K Item 2.02 (results) | $92.95 |
| Apr 30, 2026 | 8-K Item 2.02 (results) | $46.52 |
| Feb 24, 2026 | 8-K Item 2.02 (results) | $36.48 |
| Nov 4, 2025 | 8-K Item 2.02 (results) | $71.10 |
| Jul 31, 2025 | 8-K Item 2.02 (results) | $67.17 |
| May 5, 2025 | 8-K Item 2.02 (results) | $73.94 |
| Feb 26, 2025 | 8-K Item 2.02 (results) | $63.37 |
| Oct 30, 2024 | 8-K Item 2.02 (results) | $46.89 |
| Jul 29, 2024 | 8-K Item 2.02 (results) | — |
| May 1, 2024 | 8-K Item 2.02 (results) | — |
| Feb 15, 2024 | 8-K Item 2.02 (results) | — |
| Jan 8, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on CORT
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.